9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clearance of circulating endothelin-1 by ETB receptors in rats.

      Biochemical and Biophysical Research Communications
      Analysis of Variance, Animals, Endothelin Receptor Antagonists, Endothelins, blood, metabolism, pharmacokinetics, Infusions, Intravenous, Kidney, drug effects, Kinetics, Liver, Lung, Male, Metabolic Clearance Rate, Oligopeptides, administration & dosage, pharmacology, Peptides, Cyclic, Piperidines, Rats, Rats, Wistar, Receptors, Endothelin, Spleen

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Exogenous endothelin (ET) is rapidly cleared from the circulation. We investigated which ET receptor subtypes (ETA and ETB) participate in ET-1 clearance. Following an intravenous (i.v.) bolus dose of [125I]ET-1 in anesthetized rats, radioactivity was rapidly cleared from the circulation and trapped by the lungs, kidneys and liver. Tissue distribution of the radioactivity was significantly inhibited in the lungs and kidneys, but not in the liver by infusion of the ETB antagonist BQ-788 (0.1 mg/kg/min i.v.), and the ET-1 clearance rate was reduced, while the ETA antagonist BQ-123 had no such effect. Furthermore, in isolated perfused rat lungs, about 80% of bolus-injected [125I]ET-1 was retained by the lungs after one passage. The retention of ET-1 was significantly inhibited by infusion of 1 microM BQ-788, but not BQ-123. These results suggest that ETB receptors play an important role in the clearance of ET-1.

          Related collections

          Author and article information

          Comments

          Comment on this article